)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
SKAN Group
SKAN Group (SKAN) investor relations material
SKAN Group H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary18 Aug, 2026
Executive summary
Achieved strong growth in H1 2026, with all key financial metrics improving year-over-year, including order intake up 16.3% to CHF 247.6 million and net sales up 22.2% to CHF 165.5 million, driven by robust U.S. demand, organic growth, and acquisitions.
Profitability improved significantly: EBITDA reached CHF 15.3 million (margin 9.3%, up from CHF 0.9 million), and net profit was CHF 5.4 million, reflecting a turnaround from a prior-year loss.
Order backlog increased 27.8% to CHF 442.3 million, providing strong revenue visibility through 2028.
Both Equipment & Solutions and Services & Consumables segments contributed positively, with Services & Consumables now accounting for nearly 40% of group net sales.
Major project wins, successful acquisitions, and the delivery of digital twin projects enhanced differentiation and future growth prospects.
Financial highlights
Order intake: CHF 247.6 million, up 16.3% year-over-year; order backlog: CHF 442.3 million, up 27.8%.
Net sales: CHF 165.5 million, up 22.2% year-over-year (24% at constant FX); organic growth 13.3%.
EBITDA: CHF 15.3 million (margin 9.3%), up from CHF 0.9 million (margin 0.7%) in prior year.
Net profit: CHF 5.4 million for H1 2026; EBIT margin rose to 5.3% (from -3.6%).
Operating cash flow CHF 16.3 million; free cash flow CHF 2.7 million; cash balance CHF 88.5 million.
Outlook and guidance
Full-year 2026 guidance confirmed: net sales growth in the high teens and EBITDA margin between 13% and 15%.
Solid order backlog and market trends support confidence in achieving full-year and mid-term targets.
Focus remains on innovation, operational excellence, margin improvement, backlog execution, and cost discipline.
Pre-Approved Services expected to generate meaningful revenue starting next year, ramping up over 3-4 years.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from SKAN Group
- Order intake and backlog rose, sales and EBITDA fell, but 2026 outlook is strong with margin recovery.SKAN
H2 2025 - Record order intake and backlog offset lower sales and EBITDA, supporting a positive outlook.SKANH1 2025
- Strong growth in aseptic solutions driven by injectable biotech trends and innovation leadership.SKANInvestor Presentation
- Net sales up 17.2%, EBITDA margin within guidance, and robust order backlog support outlook.SKANH1 2024
- 76% stake acquisition boosts digital transformation and market reach in life sciences.SKANM&A Announcement
- Digital integration, pre-approved services, and innovation drive growth and market leadership.SKANCMD 2025
- Order intake up 21.8%, EBITDA margin 15.8%, and dividend up 14% to CHF 0.40 per share.SKANH2 2024
Next SKAN Group earnings date
H2 202623 Mar, 2027
SKAN Group
Next SKAN Group earnings date
H2 202623 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
SKAN Group AG, known for its specialization in cleanroom equipment and solutions, plays a vital role in the pharmaceutical and biotech industries. The company focuses on designing and manufacturing containment systems, isolators, and cleanroom equipment essential for sterile and safe production environments. These products are crucial in the research, development, and manufacturing processes of pharmaceuticals, ensuring the highest standards of product purity and safety are met. SKAN's offerings include advanced aseptic processing technologies and services, ranging from initial concept design to implementation and maintenance, catering to the needs of its global clientele. The company's expertise extends to providing customized solutions that address specific requirements for contamination control and cleanroom environments. The company is headquartered in Allschwil, Switzerland, and its shares are listed on the SIX.